Regulatory and Biosafety Challenges for Vaccines

سال انتشار: 1398
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 225

فایل این مقاله در 13 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJMM-14-1_002

تاریخ نمایه سازی: 10 اسفند 1399

چکیده مقاله:

The global regulatory plan for vaccines provides a unique opportunity to develop safe and effective ones with assured quality. Methods used by regulators address challenges of new products and technologies and also increase understanding of benefits and risks of existing products. First, the laboratory-based regulatory sciences evolve correlates of immunity and safety; or improve the product characterization and potency assays. Second, these sciences design clinical trial tools to analyze novel benefit-risk methodologies for vaccines, and standardize regulatory processes. The aim of the Global regulatory agenda is to transform current national efforts into a coordinated execution plan to support worldwide immunization goals. In the current article, it has been defined the role of regulatory science to improved access to effective vaccines, and identified gaps that could be addressed through that. Also, the challenges of implementing a regulatory agenda have been investigated, and proposed strategies to resolve these gaps. In this way, an appropriate agenda will enable regulators, academics and other stakeholders to work in a coordinated way to innovate in the regulatory processes in support of global immunization goals.

نویسندگان

Fatemeh Nafian

Department of Medical Biotechnology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran

Simin Nafian

Department of Stem Cell and Regenerative Medicine, Institute of Medical Biotechnology, National Institute Genetic Engineering & Biotechnology (NIGEB), Tehran, Iran

Babak Kamali Doust Azad

Department of Nano-Bioelectronics, School of Electrical and Computer Engineering, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Nguyen M, Ball R, Midthun K, Lieu TA. The Food ...
  • Burwen DR, Sandhu SK, MaCurdy TE, Kelman JA, Gibbs JM, ...
  • Destefano F, Vellozzi C. Facilitators Report, Lessons learned exercise, ECDC ...
  • Sangshetti JN, Deshpande M, Zaheer Z, Shinde DB, Arote R. ...
  • Schmeisser F, Vodeiko GM, Lugovtsev VY, Stout RR, Weir JP. ...
  • Hardy S, Eichelberger M, Griffiths E, Weir JP, Wood D, ...
  • Lee M-S, Tseng F-C, Wang J-R, Chi C-Y, Chong P, ...
  • Mao Q, Li N, Yu X, Yao X, Li F, ...
  • Luo S, Wu F, Ye X, Tao F, Tao J, ...
  • Liang Z, Mao Q, Gao Q, Li X, Dong C, ...
  • Slomski A. Vaccines for Enterovirus 71. JAMA. 2014;311(16):1602-. ...
  • Mao QY, Liao XY, Xiang YU, Nan LI, Zhu FC, ...
  • Artaud C, Kara L, Launay O. Vaccine Development: From Preclinical ...
  • Cox MM. Recombinant protein vaccines produced in insect cells. Vaccine. ...
  • Graham BS, Mascola JR, Fauci AS. Novel vaccine technologies: essential ...
  • Gristwood A. Fresh approaches to vaccine development. EMBO reports. 2018;19(8). ...
  • Barb AW, Freedberg DI, Battistel MD, Prestegard JH. NMR detection ...
  • An Y, Cipollo JF. An unbiased approach for analysis of ...
  • Haverland NA, Fox HS, Ciborowski P. Quantitative proteomics by SWATH-MS ...
  • Onions D, Cote C, Love B, Toms B, Koduri S, ...
  • Uhlenhaut C, McClenahan S, Krause PR. Use of DOP-PCR in ...
  • Victoria JG, Wang C, Jones MS, Jaing C, McLoughlin K, ...
  • Baylis SA, Finsterbusch T, Bannert N, Blümel J, Mankertz A. ...
  • Gilliland SM, Forrest L, Carre H, Jenkins A, Berry N, ...
  • Sahoo MK, Holubar M, Huang C, Mohamed-Hadley A, Liu Y, ...
  • Zaitseva M, Romantseva T, Blinova K, Beren J, Sirota L, ...
  • Grohskopf LA. Prevention and control of seasonal influenza with vaccines. ...
  • Wang TT, Palese P. Catching a moving target. Science. 2011;333(6044):834-5. ...
  • Ovsyannikova IG, Poland GA. Vaccinomics: current findings, challenges and novel ...
  • Chen RT, Shimabukuro TT, Martin DB, Zuber PL, Weibel DM, ...
  • Heyse J, Chan I. Review of statistical innovations in trials ...
  • Ball R, Horne D, Izurieta H, Sutherland A, Walderhaug M, ...
  • Bauch CT, Bhattacharyya S, Ball RF. Rapid emergence of free-riding ...
  • Martin D, Menschik D, Bryant-Genevier M, Ball R. Data mining ...
  • Chakra CNA, Pariente A, Pinet M, Nkeng L, Moore N, ...
  • Hüllermeier E. Case-based approximate reasoning: Springer Science & Business Media; ...
  • Markatou M, Don PK, Hu J, Wang F, Sun J, ...
  • Ball R, Botsis T. Can network analysis improve pattern recognition ...
  • Botsis T, Nguyen MD, Woo EJ, Markatou M, Ball R. ...
  • Pratt JW, Raiffa H, Schlaifer R. Introduction to statistical decision ...
  • Weissmahr RN, Schüpbach J, Böni J. Reverse transcriptase activity in ...
  • World Health Organization. Reverse transcriptase activity in chicken-cell derived vaccine: ...
  • Elmgren L, Li X, Wilson C, Ball R, Wang J, ...
  • Duclos P. National Immunization Technical Advisory Groups (NITAGs): guidance for ...
  • Ricciardi G, Toumi M, Weil-Olivier C, Ruitenberg E, Dankó D, ...
  • Adjagba A, Senouci K, Biellik R, Batmunkh N, Faye PC, ...
  • Chumakov KM. Methods to monitor molecular consistency of oral polio ...
  • Marko-Varga Gr, Baker MS, Boja ES, Rodriguez H, Fehniger TE. ...
  • Graham JE, Borda-Rodriguez A, Huzair F, Zinck E. Capacity for ...
  • Yu YB, Taraban MB, Wang W, Briggs KT. Improving biopharmaceutical ...
  • Zimmer J, Vieths S, Kaul S. Standardization and regulation of ...
  • Commission EP, Medicines EDftQo, Healthcare. European pharmacopoeia: Council of Europe; ...
  • Cruz-Aponte M. Metapopulation and Non-proportional Vaccination Models Overview. Advances in ...
  • نمایش کامل مراجع